The Committee will meet in open session to hear updates of the research program in the Laboratory of DNA Viruses, Division of Viral Products, Center for Biologics Evaluation and Research, FDA. The Committee will also meet in a Closed Session to discuss the intramural research program.
This meeting will be held by teleconference. The public is welcome to attend the meeting at the specified location where a speakerphone will be provided. Public participation in the meeting is limited to the use of the speakerphone in the conference room.
DATE: Nov. 20, 2008, via teleconference, 1-4 p.m.
LOCATION: National Institutes of Health, Building 29B, Conference Room C.
CONTACT: Christine Walsh or Denise Royster, Center for Biologics Evaluation and Research, 301-827-0314. More Information